Gynaecological cancer

NW Bio To Discuss Interim Phase 3 Trial Data In Industry Theater Session During ASCO

Retrieved on:

Thursday, May 31, 2018

Details will be posted on the Company's website ( www.nwbio.com ) under the heading "Most Recent Presentations" when the arrangements are completed.

Key Points:

Details will be posted on the Company's website ( www.nwbio.com ) under the heading "Most Recent Presentations" when the arrangements are completed.
The Company is also pursuing a Phase I/II trial with DCVax-Direct for all types of inoperable solid tumor cancers.
It has completed the 40-patient Phase I portion of the trial, and is preparing for the Phase II portion.
The Company previously conducted a Phase I/II trial with DCVax-L for metastatic ovarian cancer together with the University of Pennsylvania.

Retrieved on:

Thursday, May 24, 2018

LONDON, May 24, 2018 /PRNewswire/ -- Global Cervical Dysplasia Market: Scope and Methodology

Key Points:

LONDON, May 24, 2018 /PRNewswire/ -- Global Cervical Dysplasia Market: Scope and Methodology
This report on the global cervical dysplasia market analyzes the current and future prospects of the market.
Growth rates for each segment within the global cervical dysplasia market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global cervical cancer market.
The global cervical dysplasia market is segmented as follows:
Global Cervical Dysplasia Market Revenue, by Diagnosis

Retrieved on:

Thursday, May 10, 2018

Overall, the report concludes with future projections regarding the personalized cancer vaccine segment which shows an exponential growth by 2024.

Key Points:

Overall, the report concludes with future projections regarding the personalized cancer vaccine segment which shows an exponential growth by 2024.
Global Personalized Cancer Vaccine Market Opportunity & Clinical Innovation Trend Outlook 2024 Report Highlights:
Vaccines are therapeutics that helps protect body from disease.
Unlike cancer therapeutic vaccine, a preventive cancer vaccine is given to provide immunity against viruses that might cause cancer.
Most of the cancer vaccines under development are focused on the treatment of deadly and highly prevalent cancers such as Melanoma, breast cancer, lung cancer, prostate cancer and Cervical Cancer.

Retrieved on:

Wednesday, April 25, 2018

Studies have shown that automated, assisted imaging can increase the sensitivity of detecting suspicious cells compared to manual slide review.1-4

Key Points:

Studies have shown that automated, assisted imaging can increase the sensitivity of detecting suspicious cells compared to manual slide review.1-4
Most ThinPrep Pap tests are currently run in high-volume reference laboratories that employ automated imaging via the Hologic ThinPrep Imaging System.
The ThinPrep Integrated Imager combines the power of ThinPrep computer-assisted imaging and the ease of dual slide review into a single, automated microscope, bringing increased sensitivity for cervical disease detection to laboratories of all sizes.
"Approval of the ThinPrep Integrated Imager brings the benefits of ThinPrep automated Pap imaging to small- and mid-sized laboratories in the United States, and of course to their patients," said Tom West, president, Diagnostic Solutions division at Hologic.
Also able to be used as a conventional microscope, the ThinPrep Integrated Imager consolidates the needs of the cytotechnologist into one device.

Retrieved on:

Monday, April 23, 2018

WASHINGTON, April 23, 2018 /PRNewswire/ --Approximately 140,000 women around the world die of ovarian cancer every year.

Key Points:

WASHINGTON, April 23, 2018 /PRNewswire/ --Approximately 140,000 women around the world die of ovarian cancer every year.
On May 8, World Ovarian Cancer Day, Jen Coken, the daughter of a health-obsessed woman who died of the disease, is conducting a free webinar at noon EST about the symptoms of ovarian cancer and how women can talk to their doctor about them.
Coken says, "It's not enough to paint "Ovarian Cancer" on a sign and share it on Facebook.
This information has a great impact on the current and future treatment of ovarian cancer."

Retrieved on:

Thursday, April 19, 2018

The "Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.

Key Points:

The "Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.
The research provides insights into Cervical Cancer epidemiology, Cervical Cancer diagnosed patients, and Cervical Cancer treatment rate for US, Japan, and EU5 countries.
The research measures key indicators including prevalence of Cervical Cancer derived from epidemiological analysis, patients diagnosed with Cervical Cancer, and patients treated with a drug therapy.
The research provides estimates and forecasts of Cervical Cancer prevalence, Cervical Cancer diagnosis rate, and Cervical Cancer treatment rate for the period 2017 - 2026.